Navigation Links
Thomson Reuters Installs Clinical Xpert at Catholic Healthcare West for HIS Downtime Solution
Date:1/28/2009

ANN ARBOR, Mich., Jan. 28 /PRNewswire/ -- Thomson Reuters announced today that Catholic Healthcare West (CHW), the eighth largest hospital system in the United States, has implemented Clinical Xpert(TM) as its downtime solution when access to the hospital information system (HIS) and electronic patient data is temporarily unavailable.

CHW has implemented Clinical Xpert - a Thomson Reuters healthcare solution formerly called MercuryMD MData - in five of its facilities and plans to implement it across additional facilities in 2009.

Clinical Xpert integrates into virtually any IT infrastructure. It captures vital clinical data from the HIS - including admission-discharge-and-transfer information, medications, radiology reports, lab results, vital signs, and demographics - and stores them in a staging database managed by the hospital. During planned and unplanned HIS downtime, clinicians can access the staging database to retrieve the most recent clinical data for their patients - so they can continue providing informed care without interrupting their workflow.

"Clinical Xpert is a key component of Catholic Healthcare West's overall clinical information system continuity plan," said Scott Whyte, senior director of physician and ambulatory IT strategy at CHW. Though downtimes are rare, during one recent period CHW clinicians were able to access Clinical Xpert for their patient information, allowing them to continue on their rounds without interruptions.

In addition, the Clinical Xpert Navigator enables CHW clinicians to get real-time access to clinical data via their mobile devices such as Palm, Windows Mobile and BlackBerry(R) smartphones.

"CHW continually looks for ways to better serve our physicians and caregivers," said Whyte. "This mobile data solution provides the clinical data our physicians need during the course of their daily activities to deliver excellent
'/>"/>

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Thomson Reuters Publishes Three Pharma Matters Reports Covering the Third Quarter of 2008
2. Tomball Regional Medical Center Selects Clinical Xpert(TM) from Thomson Reuters to Lead Quality Improvement Initiatives
3. Thomson Reuters White Paper Explores the Role of Biomarkers in Clinical Trials and Drug Development
4. Lupus is a Significant Cost to Employers, According to Thomson Reuters Study
5. Clinical Xpert Navigator From Thomson Reuters Is Named Best Mobile Data System in the KLAS Awards - for Seventh Consecutive Year
6. BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy
7. Companies Pay a High Price for Employees With Crohns Disease and Ulcerative Colitis, According to Study From Thomson Reuters
8. Parrish Medical Center Deploys Clinical Xpert(TM) Solutions from Thomson Reuters
9. Thomson Reuters Launches Thomson Pharma KOLexperts(R) to Help the Pharmaceutical Industry Objectively Identify, Verify and Rank Scientific Experts, Product Advocates, Clinical Investigators and Key Opinion Leaders
10. Thomson Reuters Survey Finds Cancer Patients Forgoing Treatment Because of Cost
11. The Scientific Business of Thomson Reuters Predicts Nobel Laureates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... (PRWEB) May 19, 2013 Passages Malibu, ... treatment center, has announced this week the launch of ... the brands’ social media channels. “We are always ... treatment community and to get feedback regarding sobriety, what’s ... CEO and co-founder of the Passages Addiction Treatment ...
(Date:5/19/2013)... Argentina: Yoga classes ( clases de Yoga ) will ... Sivananda Yoga Vedanta Center. The center is located ... are 90 minutes and are offered all week long. ... environment, allowing visitors to enjoy the benefits of Yoga, ... , The Yoga classes follow the following principles: , ...
(Date:5/19/2013)... Ponte Vedra Beach, Florida (PRWEB) May 19, 2013 ... healthcare value and market access, is pleased to unveil ... online trade show environment that provides a powerful array ... solutions to partners in the US and abroad. , ... technology, and will offer attendees the look and feel ...
(Date:5/19/2013)... The legal team at Pulaski & ... concerted effort to connect women and families coping with ... Yaz, Yasmin & Ocella with the legal representation they ... the notorious birth control drugs as well as news ... Yaz, Yasmin & Ocella were very popular birth control ...
(Date:5/18/2013)... Cambridge House of Maryville , a BMA ... area, is hosting a Memorial Day Weekend Barbecue from 11 ... community, which is located at 6960 State Rte. 162 in ... on Medicaid, who need some help to maintain their independence. ... by homemade ice cream for dessert,” says Tracy Skaer-Henry, Administrator ...
Breaking Medicine News(10 mins):Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Metro East Affordable Assisted Living Community to Host Memorial Day Weekend Barbecue 2
... risk of breast cancer, most young women who were treated ... appropriate mammography screening, according to a study in the January ... chest radiation for a pediatric malignancy face a significantly increased ... of breast cancer begins to increase as early as 8 ...
... alternating cycles of chemotherapy and radiation have similar outcomes ... to data from a randomized controlled trial in the ... the National Cancer Institute. , Previous trials in ... followed by radiation was as effective as total removal ...
... Papillary Thyroid Cancer ,A germ-line mutation in the ... with multi-nodular goiter (MNG) and with progression to papillary thyroid ... have MNG progress to PTC, but a genetic link between ... to be involved in thyroid development and is expressed at ...
... HAMILTON, BERMUDA, Jan. 27 Warner Chilcott Limited (Nasdaq: ... year 2009 results.Total revenues for 2009 are expected to be ... results primarily being driven by LOESTRIN 24 FE, DORYX, and ... is anticipated to be in the range of 79% to ...
... to Protect World,s Supply of Donated Blood ... Continued Expansion into New Global Markets and ... PANTHER Instrument- Companies Also Plan Exploratory Collaboration ... Guidance Including Additional Revenue and Profit from ...
... Holmes (Amex: HH ) today announced the ... General Counsel and Corporate Secretary. He has also ... Rosenblum has over 23 years of corporate legal experience ... contract, consumer and other class actions, as well as ...
Cached Medicine News:Health News:Many women who survived childhood cancer do not undergo recommended breast cancer screening 2Health News:Sequential and alternating chemotherapy and radiation equally effective in larynx cancer therapy 2Health News:Also in the Jan. 27 JNCI 2Health News:Also in the Jan. 27 JNCI 3Health News:Also in the Jan. 27 JNCI 4Health News:Warner Chilcott Announces 2009 Financial Guidance 2Health News:Warner Chilcott Announces 2009 Financial Guidance 3Health News:Warner Chilcott Announces 2009 Financial Guidance 4Health News:Warner Chilcott Announces 2009 Financial Guidance 5Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 2Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 3Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 4Health News:Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration 5Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 2Health News:Hooper Holmes Names Mark Rosenblum Senior Vice President, General Counsel and Corporate Secretary 3
(Date:5/17/2013)... 2013  PENTAX Medical, a healthcare industry leader ... leader in ultrasound imaging, recently announced renewed collaborative ... further innovation in the development of Endoscopic Ultrasound ... and PENTAX Medical endoscopic portfolio have formed one ... systems. This agreement will continue to grow their ...
(Date:5/17/2013)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( ... announced today that the United States Food and Drug ... application(IND) for ORMD-0801, its oral insulin capsule. ... to proceed," stated Nadav Kidron , ... milestone for Oramed and we look forward to continuing ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
... with Two Abstracts Accepted for ... November 2008, BRIDGEWATER, N.J., Sept. 4 ... the treatment of,cardiovascular and metabolic disease, today announced ... Company,s board of directors., Peter Garrambone,s career ...
... Group (NYSE: SCR ), a leading manufacturer ... the patented,anti-cancer biotech product Endu (also known as ... Phase IV clinical study., At the request ... clinical study,to further validate the safety and therapeutic ...
Cached Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3
... reliable strength for temporary wound support. ... compliant and stretchable support material is ... is not required. Predictable absorption. Polyglactin ... inert, nonantigenic, and nonpyrogenic. ,VICRYL (polyglactin ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
... designed for the repair of abdominal hernias. ... has two distinct sides. One side ... layer of sodium hyaluronate and carboxymethylcellulose (similar ... coated side is bioresorbable, providing a temporary ...
... Human explant studies have confirmed Atriums ... maximum clinical performance in hernia repair. ... thinner and less dense hernia mesh ... rigid repair. Since 1994, when Atrium ...
Medicine Products: